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Abstract
Therapeutic ultrasound is an investigational modality which could potentially
be used for minimally invasive treatment of prostate cancer. Computational
simulations were used to study the effect of natural physiological variations in
tissue parameters on the efficacy of therapeutic ultrasound treatment in the
prostate. The simulations were conducted on a clinical ultrasound therapy sys-
tem using patient computed tomography (CT) data. The values of attenuation,
perfusion, specific heat capacity and thermal conductivity were changed within
their biological ranges to determine their effect on peak temperature and ther-
mal dose volume. Increased attenuation was found to have the biggest effect
on peak temperature with a 6.9% rise. The smallest effect was seen with per-
fusion with ±0.2% variation in peak temperature. Thermal dose was mostly
affected by specific heat capacity which showed a 20.7% increase in volume with
reduced heat capacity. Thermal conductivity had the smallest effect on thermal
dose with up to 2.1% increase in the volume with reduced thermal conductiv-
ity. These results can be used to estimate the interpatient variation during the
therapeutic ultrasound treatment of the prostate.
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Introduction
Prostate cancer is the second most common cancer occurring in men, with an
estimated 1.1 million people diagnosed worldwide in 2012 (Stewart and Wild,
2014). In the same year, approximately 0.3 million people died due to the
disease, making prostate cancer the fifth most common cause of cancer death
among men. To put these figures into perspective, prostate cancer accounts for
approximately 15% of all cancer incidences and 7% of all cancer related deaths
in men (Stewart and Wild, 2014). Patients typically experience symptoms,
such as urinary problems and pelvic pain, which reduce their quality of life.
Therefore, early diagnosis and effective treatment of the disease are essential for
the well-being and survival of the patients.
Therapeutic ultrasound is a treatment modality which could potentially pro-
vide minimally invasive therapy for prostate cancer patients. The treatment can
be delivered through a transurethral route (Burtnyk et al., 2015; Ramsay et al.,
2017) whereby the ultrasound probe is inserted into the prostate through the
urethra. The benefit of this technique is that the heat can be delivered directly
to the target location without any intervening tissue layers in between. The
therapy can then be delivered to either the complete prostate or parts of it by
controlling the rotation of the ultrasound probe.
The initial clinical evidence from transurethral ultrasound therapy of the
prostate has shown variability in efficacy (Chin et al., 2016; Ramsay et al.,
2017), which can be attributed to several factors. One possible reason might
be the physiological differences between patients. There exists natural variation
in the acoustic and thermal properties of the prostate (Parker et al., 1993; van
Vulpen et al., 2002; Patch et al., 2011; Hasgall et al., 2015), which might affect
the treatment efficacy. It has been shown that these parameters have an effect on
heating and lesion creation in other therapeutic ultrasound treatments (Billard
et al., 1990; Chen et al., 1993; Burtnyk et al., 2010).
The aim of this research is therefore to find out how much the efficacy of
ultrasound therapy in the prostate is affected by the natural variation in the
3
acoustic and thermal properties of the prostate. This is done by conducting
nonlinear ultrasound and thermal simulations on a clinical patient image data by
varying the values of attenuation, perfusion, specific heat capacity and thermal
conductivity of the prostate within their physiological ranges. The results help
to understand the scale of interpatient variability that can be expected to occur
during clinical treatments.
Therapeutic ultrasound simulations
Acoustic and thermal simulation models
The simulation geometry was derived using a three-dimensional computed
tomography (CT) dataset of a clinical patient treated at the Turku University
Hospital, Finland. The ethical permission for the study (ETMK: 152/1801/2016)
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Figure 1: Segmented computed tomography (CT) slice of half of the prostate (grey). The
tissue areas surrounding the prostate were segmented as fat (black) and muscle (light grey).
The ultrasound probe was positioned along the urethra in the middle of the prostate (the white
area on top of the image is the transducer). (b) Simulated pressure and (c) temperature fields
in the prostate during a 20-second sonication.
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was obtained from the Ethics Committee of Hospital District of Southwest Fin-
land. Intensity thresholds were first used to automatically segment the CT
data into fat, bone and muscle tissue after which the prostate was segmented
manually.
The therapeutic ultrasound probe was modelled on a clinical Tulsa-Pro sys-
tem (Profound Medical, Mississauga, Canada) (Burtnyk et al., 2015). The
system has 10 rectangular unfocused transducer elements, which are located
inside the ultrasound probe. The element size is 4.5 mm × 5.0 mm with 0 mm
element spacing which results in a total transmitting surface area of 4.5 mm ×
50.0 mm. The diameter of the ultrasound probe is approximately 5 mm with
the transducer being 2 mm inside the probe. The transducer was operated at 4
MHz frequency with continuous wave transmission. The ultrasound probe was
positioned along the urethra in the middle of the prostate so that all transducer
elements were inside the prostate. A visualisation of the prostate together with
the inserted ultrasound probe is presented in Figure 1(a) where the craniocaudal
direction is along the positive x-axis.
The ultrasound simulations were conducted using a parallelised version of
the open source k-Wave Toolbox (Treeby et al., 2012; Jaros et al., 2016). The
code solves a set of coupled first-order partial difference equations based on the
conservation laws and a phenomenological loss term that accounts for acoustic
absorption with a frequency power law. The governing equations are equivalent
to a generalised version of the Westervelt equation that accounts for second-
order acoustic nonlinearity, power law acoustic absorption, and a heterogeneous
distribution of material properties (sound speed, density, nonlinearity and ab-
sorption coefficient).
The thermal simulations were conducted by solving the Pennes bioheat trans-
fer equation. The solution took into account the specific heat capacity, thermal
conductivity and the perfusion in different tissues. The heating rate was cal-
culated using the harmonic components of the nonlinear ultrasound field. This
was done in order to accurately replicate the increased heating effect in the focal
area of the ultrasound field due to nonlinearity.
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Table 1: Acoustic simulation parameters
Density Sound speed Attenuation B/A
(kg/m3) (m/s) (dB/MHz1.1/cm)
Prostate 1045 1561 0.78 ± 0.24 7.5
Muscle 1050 1547 1.09 7.2
Fat 950 1478 0.48 10.1
Water 1000 1520 0.00217 5.2
Simulation parameters and execution
The ultrasound simulations were run on a computing cluster at CSC - IT
Centre for Science, Finland, using 256 cores, 90 GB memory and approximately
3 hours per simulation. The size of the computational grid was 1280 × 1536
× 256 grid points, i.e., 5.9 cm × 7.1 cm × 1.2 cm, which supported harmonic
frequencies up to 16 MHz (i.e., four harmonics with the sonication frequency
of 4 MHz). Temporal resolution was set to 30 points per wavelength which
corresponded to a time step of 8.3 ns.
In total, three different acoustic simulations were run using the tissue pa-
rameters in Table 1 (Mast, 2000; Hasgall et al., 2015; Parker et al., 1993). In
addition to the ‘baseline’ simulation, which was used as a reference with mean
values, the attenuation of the prostate was varied by ±0.24 dB/MHz/cm which
corresponds to one standard deviation (SD) variation in the prostate tissue
(Parker et al., 1993).
The thermal simulations were run in Matlab R2017a (MathWorks, Natick,
Massachusetts, United States) on a local desktop computer. The grid resolution
was decimated by a factor of 4 for computational efficiency and a time step
of 0.25 s was used. The thermal simulations were conducted using the tissue
parameters in Table 2 (van Vulpen et al., 2002; Patch et al., 2011; Hasgall et al.,
2015). Each simulation was run using 20-second heating time followed by 40
seconds of cooling. In addition to the baseline simulation with mean values, the
thermal conductivity, specific heat capacity and perfusion rate of the prostate
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Table 2: Thermal simulation parameters
Thermal Specific Perfusion
conductivity heat capacity rate
(W/m/K) (J/kg/K) (kg/m3/s)
Prostate 0.51 ± 0.03 3400 ± 300 1.7 ± 1.3
Muscle 0.49 3421 0.6
Fat 0.21 2348 0.6
Water 0.60 4178 0
Blood N/A 3617 N/A
were varied by ±0.03 W/m/K, ±300 J/kg/K and ±1.3 kg/m3/s, respectively,
which correspond to one SD change measured in the prostate (van Vulpen et al.,
2002; Patch et al., 2011; Hasgall et al., 2015). The temperature of the water
inside the ultrasound probe was held constant at 21 ◦C to mimic the cooling
effect of the room temperature water flowing through the clinical system. The
perfusion rate was set to zero for tissue regions which reached a thermal dose
of 240 cumulative equivalent minutes at 43 ◦C (CEM).
Results
A visualisation of the segmented CT data together with the simulated ul-
trasound and temperature fields are shown in Figure 1. The ultrasound field
in Figure 1(b) can be seen to exit the transducer into the prostate with the
highest pressure region occurring near the transducer face. Some high pressure
regions can also be seen in the regions where the ultrasound field is transmitted
from the prostate tissue into the fat and muscle. Similarly, the temperature
field in Figure 1(c) can be seen forming close to the transducer where the high
pressure regions are located. The peak temperatures were observed to occur
approximately at y = 5 mm from the transducer face. The locations at y = 2
mm and closer are at 21 ◦C due to the water cooling.
Figure 2 shows the temperature evolution during the heating and cooling
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Table 3: The variation in the peak temperatures and thermal dose volumes
Baseline Attenuation Perfusion Specific Thermal
heat capacity conductivity
−SD +SD −SD +SD −SD +SD −SD +SD
Maximum temperature (◦C) 72.3 65.3 77.3 72.4 72.2 74.5 70.3 73.1 71.6
Difference (from baseline) (◦C) 0.0 −7.0 5.0 0.1 −0.1 2.2 −2.0 0.8 −0.8
Difference (from baseline) (%) 0.0 −9.7 6.9 0.2 −0.2 3.1 −2.7 1.1 −1.0
Thermal dose volume (cm3) 2.6 2.3 2.7 2.7 2.5 3.1 2.2 2.6 2.5
Difference (from baseline) (cm3) 0.0 −0.2 0.1 0.1 −0.1 0.5 −0.3 0.1 0.0
Difference (from baseline) (%) 0.0 −9.1 5.8 4.5 −2.9 20.7 −12.8 2.1 −1.6
recorded at 5 mm away from the geometric centre of the transducer (the origin in
the coordinates). The baseline curve in each figure corresponds to the simulation
with mean values while the two other curves show the specific tissue property
changed by ±SD. In Figure 3 are shown the differences in peak temperature and
thermal dose with respect to the baseline sonication. Figures 3(a)-(b) show the
absolute differences in temperature and thermal dose, respectively, while Figures
3(c)-(d) are normalised to the baseline value. Table 3 lists the corresponding
numerical values for maximum temperature and thermal dose in each individual
case.
Figure 2(a) shows the effect of attenuation on heating during the sonication.
Increasing the attenuation by one SD resulted in 6.9% higher peak temperature
at the end of the sonication. This is because the heating rate of the ultrasound
field is directly proportional to absorption. Similarly, decreasing the attenu-
ation by one SD resulted in a 9.7% decrease in the peak temperature. The
corresponding 240 CEM thermal doses for increased and decreased attenuation
exhibited similar behaviour with a 5.8% and −9.1% change from the baseline,
respectively.
The effect of perfusion on temperature evolution is shown in Figure 2(b). For
the given perfusion values, the effect on heating is negligible. Changing perfusion
±SD from the baseline resulted in approximately ∓0.2% deviation in maximum
temperature. This is likely due to the fact that the perfusion was relatively
small to begin with and that the perfusion diminished to zero quite fast in the
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regions where 240 CEM thermal dose was achieved. The corresponding effect
on thermal dose was a magnitude larger with a −2.9% and 4.5% change for
increased and decreased perfusion rate, respectively. This is due to the cooling
effect of perfusion in the tissue regions which are surrounding the necrotic (i.e.,
240 CEM) tissue thus reducing its growth speed.
In Figure 2(c) is shown the effect of varying specific heat capacity. Heat
capacity specifies the amount of thermal energy needed to increase the temper-
ature of the tissue. Therefore, the reduction in heat capacity results higher peak
temperature and vice versa, with the corresponding changes in the maximum
temperature being 3.1% and −2.7%, respectively. The effect on thermal dose
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Figure 2: The effect of the variation in (a) attenuation, (b) perfusion, (c) specific heat capacity
and (d) thermal conductivity on temperature during 20-second sonication followed by a 40-
second cooling period.
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was drastically larger with 20.7% and −12.8% deviations from the baseline for
the decreased and increased heat capacity, respectively. This means that addi-
tional tissue regions were able to achieve sufficient temperatures to exceed the
thermal dose threshold with the given sonication duration.
The last tissue parameter studied was thermal conductivity which is shown
in Figure 2(d). Increasing thermal conductivity by one SD resulted in 1.0%
decrease in peak temperature. A similar effect was seen with decreased thermal
conductivity which increased the peak temperature by 1.1%. The effect on
thermal dose was similar with a −1.6% and 2.1% change from the baseline with
increased and decreased thermal conductivity, respectively.
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Figure 3: The difference in (a) peak temperature and (b) thermal dose volume with respect to
the baseline value when attenuation, perfusion, specific heat capacity and thermal conductivity
are varied within their physical ranges. (c)-(d) The same graphs normalised to the baseline
value.
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Discussion
Among the studied tissue parameters, the biggest effect on peak temperature
was caused by the changes in attenuation. One SD increase in attenuation
resulted in a 6.9% higher peak temperature. The temperature evolution was
studied at 5 mm from the transducer face where the increase in attenuation
shows as a higher heating rate. On the other hand, tissue regions further away
from the transducer exhibit lower heating due to a reduction in intensity with
ultrasound propagation distance. Therefore, higher attenuation of the prostate
shows up as increased heating in locations close to the transducer.
Perhaps surprisingly, the changes in perfusion had the smallest effect on peak
temperature. As mentioned earlier, the perfusion in the prostate is relatively
small to start with (about one sixth of that in kidney medulla (Roberts et al.,
1995)), and thus, the changes to it did not have a big effect on the temperature
evolution. Furthermore, the perfusion was set to zero in the tissue regions over
240 CEM which further diminished its effect on temperature. These results
are consistent with earlier studies which show that perfusion does not have
noticeable effect on the predictability and efficacy of the ultrasound therapy in
the prostate (Rouvie`re et al., 2004; Kirkham et al., 2008).
The biggest effect on 240 CEM thermal dose was seen in the variations
of specific heat capacity. One SD decrease in specific heat capacity showed
20.7% increase in thermal dose volume. The smallest effect on thermal dose
was caused by the changes in thermal conductivity. These values present the
scale of variation might be expected during a clinical treatment.
It should be noted that some of the tissue properties are also temperature
dependent, which the simulation model did not take into account (van Vulpen
et al., 2002). Furthermore, tumorous tissue might exhibit different properties
to healthy tissue (Inaba, 1992).
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Conclusions
The effect of natural physiological variation in attenuation, perfusion, spe-
cific heat capacity and thermal conductivity on the efficacy of therapeutic ultra-
sound treatment in the prostate was studied. It was found that with the given
sonication duration, attenuation had the biggest effect on temperature while
perfusion had the smallest. Thermal dose was mostly affected by the variations
in specific heat capacity whereas thermal conductivity had the smallest effect.
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